Gentag

  Mayo Clinic and Gentag, Inc. has signed a joint intellectual property (IP) agreement to develop the next generation of wearable biosensors designed to fight obesity and diabetes. Together, both parties plan to create a wireless, disposable wearable patch sensor about the size of a small bandage that communicates via a closed-loop diabetes management platform integrated with your smart phone. The integrated system will allow researchers to monitor movement and develop treatments for
Read More